Replies to post #19 on Medifast Inc. (MED)

[expat7]

2 Most Recently Initiated Coverage with Target @$16

01-19-2007 09:08:21 AM
1.) BB&T CAPITAL
TARGET: $16.00
BB&T CAPITAL initiates coverage on Medifast (AMEX: MED)
with a Buy rating and $16 price target.

Medifast is the leading easy-to-use, clinically proven meal replacement program. Medifast has been recommended by 15,000 physicians and used by over one million customers. Its programs have been proven effective through studies by researchers from major university teaching hospitals.
http://www.streetinsider.com/New+Coverage/BB&T+Capital+Starts+Medifast+(MED)+at+Buy/1509308.html

January 21, 2007 9:28:58 AM ET
2) eResearch
TARGET: 16.00
Medifast initiated with "buy"
January 21, 2007 9:28:58 AM ET
eResearch

NEW YORK, January 22 (newratings.com) - Analyst Laura Richardson of eResearch initiates coverage of Medifast Inc (MDF.ETR) with a "buy" rating. The 12-month target price is set to $16.

In a research note published on January 19, the analyst mentions that the company is well positioned to benefit going forward from weight-related concerns and is poised to capitalize on this trend through an increase in its ad spending. Medifast faces an opportunity to generate over $700 million in revenues in the forthcoming five-to-ten years, the analyst says. The company is expected to achieve 38% and 30% earnings growth this year and in the long-term, respectively, eResearch adds.
http://www.newratings.com/analyst_news/article_1460039.html